Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.43
-2.21 (-1.05%)
AAPL  272.31
-1.92 (-0.70%)
AMD  203.25
-7.61 (-3.61%)
BAC  52.33
+0.64 (1.24%)
GOOG  306.34
-6.69 (-2.14%)
META  655.83
+2.14 (0.33%)
MSFT  401.89
+1.29 (0.32%)
NVDA  187.41
-8.15 (-4.17%)
ORCL  148.47
+0.59 (0.40%)
TSLA  409.00
-8.40 (-2.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.